719 related articles for article (PubMed ID: 9724636)
21. Cooperative signals governing ARF-mdm2 interaction and nucleolar localization of the complex.
Weber JD; Kuo ML; Bothner B; DiGiammarino EL; Kriwacki RW; Roussel MF; Sherr CJ
Mol Cell Biol; 2000 Apr; 20(7):2517-28. PubMed ID: 10713175
[TBL] [Abstract][Full Text] [Related]
22. CARF is a novel protein that cooperates with mouse p19ARF (human p14ARF) in activating p53.
Hasan MK; Yaguchi T; Sugihara T; Kumar PK; Taira K; Reddel RR; Kaul SC; Wadhwa R
J Biol Chem; 2002 Oct; 277(40):37765-70. PubMed ID: 12154087
[TBL] [Abstract][Full Text] [Related]
23. Mutations in the INK4a/ARF melanoma susceptibility locus functionally impair p14ARF.
Rizos H; Darmanian AP; Holland EA; Mann GJ; Kefford RF
J Biol Chem; 2001 Nov; 276(44):41424-34. PubMed ID: 11518711
[TBL] [Abstract][Full Text] [Related]
24. INK4a/ARF locus alterations in human non-Hodgkin's lymphomas mainly occur in tumors with wild-type p53 gene.
Pinyol M; Hernández L; Martínez A; Cobo F; Hernández S; Beà S; López-Guillermo A; Nayach I; Palacín A; Nadal A; Fernández PL; Montserrat E; Cardesa A; Campo E
Am J Pathol; 2000 Jun; 156(6):1987-96. PubMed ID: 10854221
[TBL] [Abstract][Full Text] [Related]
25. Nucleolar p14(ARF) overexpression in Reed-Sternberg cells in Hodgkin's lymphoma: absence of p14(ARF)/Hdm2 complexes is associated with expression of alternatively spliced Hdm2 transcripts.
García JF; Villuendas R; Sánchez-Beato M; Sánchez-Aguilera A; Sánchez L; Prieto I; Piris MA
Am J Pathol; 2002 Feb; 160(2):569-78. PubMed ID: 11839577
[TBL] [Abstract][Full Text] [Related]
26. Contribution of two independent MDM2-binding domains in p14(ARF) to p53 stabilization.
Lohrum MA; Ashcroft M; Kubbutat MH; Vousden KH
Curr Biol; 2000 May; 10(9):539-42. PubMed ID: 10801444
[TBL] [Abstract][Full Text] [Related]
27. Genetic alterations of INK4alpha/ARF locus and p53 in human hepatocellular carcinoma.
Peng CY; Chen TC; Hung SP; Chen MF; Yeh CT; Tsai SL; Chu CM; Liaw YF
Anticancer Res; 2002; 22(2B):1265-71. PubMed ID: 12168936
[TBL] [Abstract][Full Text] [Related]
28. MDM2 is an important prognostic and predictive factor for platin-pemetrexed therapy in malignant pleural mesotheliomas and deregulation of P14/ARF (encoded by CDKN2A) seems to contribute to an MDM2-driven inactivation of P53.
Walter RF; Mairinger FD; Ting S; Vollbrecht C; Mairinger T; Theegarten D; Christoph DC; Schmid KW; Wohlschlaeger J
Br J Cancer; 2015 Mar; 112(5):883-90. PubMed ID: 25668009
[TBL] [Abstract][Full Text] [Related]
29. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.
Tannapfel A; Busse C; Weinans L; Benicke M; Katalinic A; Geissler F; Hauss J; Wittekind C
Oncogene; 2001 Oct; 20(48):7104-9. PubMed ID: 11704835
[TBL] [Abstract][Full Text] [Related]
30. Oncogenic ras activates the ARF-p53 pathway to suppress epithelial cell transformation.
Lin AW; Lowe SW
Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5025-30. PubMed ID: 11309506
[TBL] [Abstract][Full Text] [Related]
31. Loss of p21 disrupts p14 ARF-induced G1 cell cycle arrest but augments p14 ARF-induced apoptosis in human carcinoma cells.
Hemmati PG; Normand G; Verdoodt B; von Haefen C; Hasenjäger A; Güner D; Wendt J; Dörken B; Daniel PT
Oncogene; 2005 Jun; 24(25):4114-28. PubMed ID: 15750619
[TBL] [Abstract][Full Text] [Related]
32. The early growth response gene EGR-1 behaves as a suppressor gene that is down-regulated independent of ARF/Mdm2 but not p53 alterations in fresh human gliomas.
Calogero A; Arcella A; De Gregorio G; Porcellini A; Mercola D; Liu C; Lombari V; Zani M; Giannini G; Gagliardi FM; Caruso R; Gulino A; Frati L; Ragona G
Clin Cancer Res; 2001 Sep; 7(9):2788-96. PubMed ID: 11555594
[TBL] [Abstract][Full Text] [Related]
33. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.
Kanellou P; Zaravinos A; Zioga M; Stratigos A; Baritaki S; Soufla G; Zoras O; Spandidos DA
Cancer Lett; 2008 Jun; 264(1):145-61. PubMed ID: 18331779
[TBL] [Abstract][Full Text] [Related]
34. Correlation between p14(ARF)/p16(INK4A) expression and HPV infection in uterine cervical cancer.
Kanao H; Enomoto T; Ueda Y; Fujita M; Nakashima R; Ueno Y; Miyatake T; Yoshizaki T; Buzard GS; Kimura T; Yoshino K; Murata Y
Cancer Lett; 2004 Sep; 213(1):31-7. PubMed ID: 15312681
[TBL] [Abstract][Full Text] [Related]
35. Alterations of the p16(INK4) locus in human malignant mesothelial tumors.
Hirao T; Bueno R; Chen CJ; Gordon GJ; Heilig E; Kelsey KT
Carcinogenesis; 2002 Jul; 23(7):1127-30. PubMed ID: 12117769
[TBL] [Abstract][Full Text] [Related]
36. Alterations of the INK4a-ARF gene locus in pleomorphic adenoma of the parotid gland.
Weber A; Langhanki L; Schütz A; Wittekind C; Bootz F; Tannapfel A
J Pathol; 2002 Nov; 198(3):326-34. PubMed ID: 12375265
[TBL] [Abstract][Full Text] [Related]
37. A novel ARF-binding protein (LZAP) alters ARF regulation of HDM2.
Wang J; He X; Luo Y; Yarbrough WG
Biochem J; 2006 Jan; 393(Pt 2):489-501. PubMed ID: 16173922
[TBL] [Abstract][Full Text] [Related]
38. Immortalization of human mammary epithelial cells is associated with inactivation of the p14ARF-p53 pathway.
Shamanin VA; Androphy EJ
Mol Cell Biol; 2004 Mar; 24(5):2144-52. PubMed ID: 14966292
[TBL] [Abstract][Full Text] [Related]
39. p53 stabilization and functional impairment in the absence of genetic mutation or the alteration of the p14(ARF)-MDM2 loop in ex vivo and cultured adult T-cell leukemia/lymphoma cells.
Takemoto S; Trovato R; Cereseto A; Nicot C; Kislyakova T; Casareto L; Waldmann T; Torelli G; Franchini G
Blood; 2000 Jun; 95(12):3939-44. PubMed ID: 10845931
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical inactivation of p14ARF concomitant with MDM2 overexpression inversely correlates with p53 overexpression in oral squamous cell carcinoma.
Sano T; Hikino T; Xue Q; Saito T; Kashiwabara K; Oyama T; Nakajima T
Pathol Int; 2000 Sep; 50(9):709-16. PubMed ID: 11012984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
